Massachusetts House dilutes Medicaid drug pricing bill

The Massachusetts House of Representatives Wednesday took some of the sting out of Medicaid drug price regulation provisions that will be incorporated into a budget bill, passing an amendment that scraps requirements for drug manufacturers to publicly justify prices and eliminates a mandate for a state commission to publish proposed values

Read the full 510 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE